Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 3

1(25.0%)

4Total

N/A(3)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT03674255Enrolling By Invitation

Echocardiography: Value and Accuracy at REst and STress

Role: collaborator

NCT05727020Recruiting

Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma

Role: collaborator

NCT07432620Active Not Recruiting

Artificial Intelligence Stress Echo (FINESSE) Project

Role: lead

NCT07235579Completed

Understanding Cauda Equina Syndrome

Role: collaborator

NCT05262374Completed

Versius or Laparoscopic TransAbdominal Inguinal Hernia REpair

Role: lead

NCT05058690Not ApplicableNot Yet Recruiting

Artificial Intelligence to Improve Cardiometabolic Risk Evaluation Using CT Scans

Role: collaborator

NCT06622980Not ApplicableCompleted

The Effect of an Ergonomic Educational Intervention on Laparoscopic Surgeons' Ergonomic Risk Scores (ErgoEd)

Role: lead

NCT01795833Not ApplicableCompleted

Diabetes Prevention Using SMS Technology

Role: collaborator

NCT02153515Phase 3Unknown

Treating Dry Eyes and Corneal Ulcers With Fingerprick Autologous Blood

Role: collaborator

All 9 trials loaded